Efficacy of Primaquine in Preventing Short- and Long-Latency Plasmodium vivax Relapses in Nepal

BACKGROUND: Plasmodium vivax is the main cause of malaria in Nepal. Relapse patterns have not been characterized previously. METHODS: Patients with P. vivax malaria were randomized to receive chloroquine (CQ; 25 mg base/kg given over 3 days) alone or together with primaquine (PQ; 0.25 mg base/kg/day...

Descripción completa

Detalles Bibliográficos
Autores principales: Rijal, Komal Raj, Adhikari, Bipin, Ghimire, Prakash, Banjara, Megha Raj, Das Thakur, Garib, Hanboonkunupakarn, Borimas, Imwong, Mallika, Chotivanich, Kesinee, Day, Nicholas P J, White, Nicholas J, Pukrittayakamee, Sasithon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603971/
https://www.ncbi.nlm.nih.gov/pubmed/30882150
http://dx.doi.org/10.1093/infdis/jiz126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6603971/
https://www.ncbi.nlm.nih.gov/pubmed/30882150
http://dx.doi.org/10.1093/infdis/jiz126

Ejemplares similares